MIMETAS B.V.

Leiden, 
Netherlands
  • Booth: 1651

MIMETAS develops organ-on-a-chip technology for drug screening in 3D-tissues. Our unique microfluidic platform enables testing of compounds in high-throughput on miniaturized organ models. These models offer better predictivity as compared to laboratory animal testing and conventional cell culture models. The MIMETAS OrganoPlate™ platform supports 3D cell culture under continuous perfusion, membrane-free co-culture and boundary- and gradient formation, thus mimicking important aspects of tissues and organs. 


Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".